DavidAndrewPistenmaaMD
Radiation Oncology • Dallas, TXProfessor of Radiation Oncology, University Tex SW Dallas
Dr. Pistenmaa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8525Fax+1 214-645-8526
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 1970 - 1973
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1969 - 1970
Stanford University School of MedicineClass of 1969
Certifications & Licensure
TX State Medical License 1993 - 2016
VA State Medical License 1983 - 2014- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
- Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery Start of enrollment: 2010 May 26
Publications & Presentations
PubMed
- 142 citationsPredictors of Rectal Tolerance Observed in a Dose-Escalated Phase 1-2 Trial of Stereotactic Body Radiation Therapy for Prostate CancerD. W Nathan Kim, L. Chinsoo Cho, Christopher Straka, Alana Christie, Yair Lotan
International Journal of Radiation Oncology, Biology, Physics. 2014-07-01 - 180 citationsPhase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerT. Boike, Yair Lotan, L. Chinsoo Cho, Jeffrey Brindle, Paul DeRose
Journal of Clinical Oncology. 2011-05-20 - 110 citationsStereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.Raquibul Hannan, Vasu Tumati, Xian Jin Xie, L. Chinsoo Cho, Brian D. Kavanagh
European Journal of Cancer. 2016-05-01
Press Mentions
First Person Profile: C. Norman Coleman, MDSeptember 3rd, 2020
New UT Southwestern Moncrief Medical Center at Fort Worth Enhances Access to Care for Tarrant County ResidentsJune 1st, 2017
Simmons Cancer Center Recognized for Comprehensive CareSeptember 2nd, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
